Dr. Carlos Eduardo Silva Correia
Claim this profileJersey Shore Medical Center
Area of expertise
Brain Tumor
Carlos Eduardo Silva Correia has run 5 trials for Brain Tumor. Some of their research focus areas include:
Glioblastoma
Carlos Eduardo Silva Correia has run 3 trials for Glioblastoma. Some of their research focus areas include:
Affiliated Hospitals
Jersey Shore Medical Center
Clinical Trials Carlos Eduardo Silva Correia is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting
2 awards
Phase 3
4 criteria
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting
1 award
Phase 2
10 criteria
More about Carlos Eduardo Silva Correia
Clinical Trial Related
3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Carlos Eduardo Silva Correia has experience with
- Temozolomide
- Abemaciclib
- Atezolizumab
- Tocilizumab
- Fractionated Stereotactic Radiation Therapy
- Lomustine
Breakdown of trials Carlos Eduardo Silva Correia has run
Brain Tumor
Glioblastoma
Protoplasmic Astrocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Carlos Eduardo Silva Correia specialize in?
Carlos Eduardo Silva Correia focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved IDH positive patients, or patients who are 1p/19q co-deletion positive.
Is Carlos Eduardo Silva Correia currently recruiting for clinical trials?
Yes, Carlos Eduardo Silva Correia is currently recruiting for 3 clinical trials in Neptune New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Carlos Eduardo Silva Correia has studied deeply?
Yes, Carlos Eduardo Silva Correia has studied treatments such as Temozolomide, Abemaciclib, Atezolizumab.
What is the best way to schedule an appointment with Carlos Eduardo Silva Correia?
Apply for one of the trials that Carlos Eduardo Silva Correia is conducting.
What is the office address of Carlos Eduardo Silva Correia?
The office of Carlos Eduardo Silva Correia is located at: Jersey Shore Medical Center, Neptune, New Jersey 07753 United States. This is the address for their practice at the Jersey Shore Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.